FDA boosts transparency to 77%

The FDA's mighty efforts to become a more transparent government agency, beginning with a transparency task force, convened in June, are yielding results, says blogger Mark Senak. His transparency metric of advisory committee rosters that include links to committee member CVs has seen a rise to 77 percent, up from 50 percent. Blog

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.